Skip to main content
Clinical Trials/IRCT20141009019470N71
IRCT20141009019470N71Not yet recruitingPhase 2

The Effect of Melatonin on interleukin 13 and interleukin 22 in patients undergoing Coronary Artery Bypass Graft Surgery

Shiraz University of Medical Sciences0 sites42 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
42

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
40 years to 75 years (—)
Sex
All

Inclusion Criteria

  • En Patients who are candidate for elective CABG
  • Age between 40-75 years old
  • ASA class Pump time less than 90 min; graft number between 2 to 6.
  • Graft number between 2 to 6.

Exclusion Criteria

  • pregnancy and breast feeding
  • local or systemic infection
  • hyper sensitivity
  • redo surgery
  • surgery during last 6 months
  • collagen vascular disease
  • immunosuppressive disease
  • heart failure with ejection fraction less than 35%
  • recent cardiovascular event
  • uncontrolled HTN
  • renal failure
  • liver failure
  • alcohol abuser
  • simultaneously valvular heart surgery.

Investigators

Similar Trials